Schedule Dispatches

Schedule dispatches give a summary of changes coming out in the next month.

This is an early notification of the changes to be announced in the Update to the Pharmaceutical Schedule.

The full Update is available as a PDF(external link)

The changes will be published in the online Schedule around the 23rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz

New Listings

  • Aminoacid formula without methionine (HCU Lophlex LQ) liquid (juicy berries), 125 ml bottle – Special Authority – Hospital pharmacy [HP3] (p’code 2711478)
  • Aminoacid formula without valine, leucine and isoleucine (MSUD Lophlex LQ 20) liquid (juicy berries) 125 ml pouches – Special Authority – Hospital pharmacy [HP3] (p’code 2711451)
  • Chloramphenicol (Chlorafast) eye drops 0.5%, 10 ml OP (p’code 2368137)
  • Clindamycin (Dalacin C) inj 150 mg per ml, 4 ml ampoule (p’code 2387131)
  • Dexamethasone phosphate (Dexamethasone Medsurge) inj 4 mg per ml, 1 ml (p’code 2690497) and inj 4 mg per ml, 2 ml ampoule (p’code 2690535) – up to 5 inj available on a PSO
  • Disopyramide phosphate (Rythmodan Neon) cap 100 mg – s29 and wastage claimable (p’code 2713616)
  • Mesalazine tab 400 mg (Octasa) (p’code 2714523) and tab 800 mg (Asacol S29) (p’code 2676982) – s29 and wastage claimable
  • Nirmatrelvir with ritonavir (Paxlovid) tab 150 mg with ritonavir 100 mg, 30 OP – PCT and subsidy by endorsement (p’code 2711613)
  • Podophyllotoxin (Condyline S29) soln 0.5%, 3.5 ml OP – maximum of 3.5 ml per prescription, only on a prescription and s29 (p’code 2714205)
  • Sunitinib (Sunitinib Rex) cap 12.5 mg (p’code 2675463) and cap 25 mg (p’code 2675471) – Special Authority – Retail pharmacy
  • Venlafaxine (Enlafax XR) cap 37.5 mg (p’code 2713403) and cap 75 mg (p’code 2713411)
  • Zinc sulphate (Zincaps S29) cap 137.4 mg (50 mg elemental) – s29 and wastage claimable (p’code 2714019)

Changes to restrictions, chemical names and presentations

  • Capsaicin crm 0.025%, 45 g OP (Zo-Rub Osteo) and crm 0.075%, 45 g OP (Zo-Rub HP) – removal of s29
  • Ferrous sulfate (Ferrograd) tab long-acting 325 mg (105 mg elemental) – amended note
  • Ipratropium bromide (Atrovent) aerosol inhaler, 20 mcg per dose CFC-free, 200 dose OP – removal of no patient co-payment payable
  • Midazolam (Midazolam-Pfizer) inj 1 mg per ml, 5 ml plastic ampoule and inj 5 mg per ml, 3 ml plastic ampoule – amended brand name
  • Nirmatrelvir with ritonavir (Paxlovid (Pharmac) and Paxlovid) tab 150 mg with ritonavir 100 mg – amended subsidy by endorsement and brand name, Xpharm moved from chemical to presentation, removal of no patient co-payment payable and addition of PCT
  • Vildagliptin (Galvus) tab 50 mg – addition of stat dispensing
  • Vildagliptin with metformin hydrochloride (Galvumet) tab 50 mg with 850 mg metformin hydrochloride and tab 50 mg with 1,000 mg metformin hydrochloride – addition of stat dispensing

Increased subsidy

Chemical

Presentation

Fully subsidised brands

Ascorbic acid

Tab 100 mg

Cvite

Fluoxetine hydrochloride

Cap 20 mg

Arrow-Fluoxetine

Lisinopril

Tab 5 mg, 10 mg and 20 mg

Teva Lisinopril

Lidocaine [lignocaine]

Crm 4%, 5 g OP and 30 g OP

LMX4

Olopatadine

Eye drops 0.1%, 5 ml OP

Olopatadine Teva

Oral feed (powder)

Powder (chocolate) and (vanilla), 850 g OP

Ensure

Oxytocin 

Inj 5 iu and 10 iu per ml, 1 ml ampoule

Oxytocin BNM

Spironolactone

Tab 25 mg and 100 mg

Spiractin

Sodium cromoglicate

Eye drops 2%, 10 ml OP

Allerfix

Decreased subsidy

Chemical

Presentation

Fully subsidised brands

Fluoxetine hydrochloride

Tab dispersible 20 mg, scored

Fluox